Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China · Delayed Price · Currency is CNY 13.73
+0.27 (2.01%)
May 29, 2026, 3:04 PM CST
Cachet Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 4,005 | 4,189 | 3,769 | 4,145 | 4,198 | 4,104 | |
Market Cap Growth | 9.58% | 11.15% | -9.08% | -1.25% | 2.27% | -0.28% |
Enterprise Value | 5,033 | 5,826 | 6,389 | 7,913 | 9,077 | 7,930 |
Last Close Price | 13.73 | 14.36 | 12.76 | 13.71 | 13.57 | 12.92 |
PE Ratio | 39.10 | 37.61 | 23.83 | 16.58 | 14.14 | 11.60 |
Forward PE | - | 11.43 | 11.43 | 12.96 | 6.92 | 6.92 |
PS Ratio | 0.21 | 0.22 | 0.16 | 0.14 | 0.16 | 0.16 |
PB Ratio | 0.68 | 0.71 | 0.63 | 0.68 | 0.71 | 0.73 |
P/TBV Ratio | 1.00 | 1.05 | 0.97 | 1.11 | 1.19 | 1.25 |
P/FCF Ratio | 3.32 | 3.06 | 22.85 | 2.97 | - | 6.16 |
P/OCF Ratio | 3.26 | 3.01 | 20.90 | 2.60 | - | 4.50 |
PEG Ratio | - | 1.63 | 1.63 | 6.48 | 0.56 | 0.56 |
EV/Sales Ratio | 0.27 | 0.30 | 0.27 | 0.26 | 0.35 | 0.31 |
EV/EBITDA Ratio | 13.12 | 14.62 | 10.40 | 9.14 | 9.18 | 7.12 |
EV/EBIT Ratio | 16.50 | 15.53 | 11.38 | 10.80 | 10.92 | 8.15 |
EV/FCF Ratio | 4.18 | 4.26 | 38.74 | 5.67 | - | 11.90 |
Debt / Equity Ratio | 0.30 | 0.33 | 0.48 | 0.68 | 0.74 | 0.76 |
Debt / EBITDA Ratio | 4.68 | 4.18 | 4.17 | 4.40 | 4.13 | 3.65 |
Debt / FCF Ratio | 1.49 | 1.41 | 17.38 | 2.95 | - | 6.44 |
Net Debt / Equity Ratio | -0.08 | -0.11 | 0.11 | 0.20 | 0.37 | 0.35 |
Net Debt / EBITDA Ratio | -1.52 | -1.59 | 1.05 | 1.42 | 2.21 | 1.75 |
Net Debt / FCF Ratio | -0.40 | -0.46 | 3.89 | 0.88 | -6.21 | 2.93 |
Asset Turnover | 1.48 | 1.46 | 1.54 | 1.78 | 1.67 | 1.76 |
Inventory Turnover | 6.78 | 7.05 | 8.46 | 10.69 | 9.89 | 11.19 |
Quick Ratio | 1.35 | 1.29 | 1.20 | 1.15 | 1.10 | 1.16 |
Current Ratio | 1.86 | 1.75 | 1.64 | 1.44 | 1.44 | 1.47 |
Return on Equity (ROE) | 1.30% | 1.71% | 5.24% | 6.27% | 8.09% | 10.96% |
Return on Assets (ROA) | 1.50% | 1.75% | 2.25% | 2.72% | 3.30% | 4.19% |
Return on Invested Capital (ROIC) | 1.81% | 2.31% | 4.66% | 6.44% | 7.68% | 9.49% |
Return on Capital Employed (ROCE) | 5.10% | 6.30% | 9.20% | 11.70% | 13.50% | 16.50% |
Earnings Yield | 2.58% | 2.66% | 4.20% | 6.03% | 7.07% | 8.62% |
FCF Yield | 30.10% | 32.69% | 4.38% | 33.68% | -8.38% | 16.23% |
Dividend Yield | 0.84% | 0.80% | 1.33% | 1.90% | 2.28% | 2.86% |
Payout Ratio | 78.84% | 97.75% | 105.97% | 85.72% | 95.07% | 68.57% |
Buyback Yield / Dilution | -0.65% | -0.09% | -0.71% | 0.12% | 0.46% | -0.38% |
Total Shareholder Return | 0.19% | 0.71% | 0.62% | 2.02% | 2.74% | 2.49% |